Rocket One Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Rocket One Inc. (RKTO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-05-15
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-06-30 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 2.00K shares, a 92.09% decline from fiscal 2023.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 25.29K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-27 | 2.00K shares 10-K · filed 2026-03-27 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 2.00K shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 2.00K shares 10-Q · filed 2024-08-09 | ||
| 2024-03-31 | 2.00K shares 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 25.29K shares 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |